Crestor^® tier status changing on custom drug list

As part of our ongoing efforts to promote cost-effective, high-quality prescription drug therapy, Crestor^® will become nonpreferred on the Blue Cross Blue Shield of Michigan and Blue Care Network Custom Formulary.

This change, which is effective July 1, 2013, doesn’t apply to members with BCN Advantage^SM, Blue Cross Complete of Michigan or Blue Cross Medicare Part D. Affected members were notified by letter in late May. Blues customers with a two-tier closed drug benefit who are currently on Crestor can continue therapy with their current copayment and, therefore, didn’t receive a letter.

Other members with a two-tier closed drug benefit will be required to obtain a medical necessity authorization before they can receive Crestor. Members enrolled in a three-tier drug benefit will be charged a nonpreferred-brand copayment.

In our letters to customers, we encouraged them to contact their physicians to discuss other treatment options, including atorvastatin (Lipitor^®), lovastatin (Mevacor^®), pravastatin sodium (Pravachol^®) and simvastatin (Zocor^®).

Check our website to view our drug lists.

If you have any questions about our pharmacy programs, call the Pharmacy Services Clinical help desk at
1-800-437-3803 and select option 1.